RVX Chart by TradingView

Business Description

Resverlogix is a biotechnology company focused on the two largest drug markets – cancer and cholesterol. Its unique technology is focused on increasing HDL’s (good cholesterol) as opposed to the more common focus of lowering LDL’s (bad cholesterol).

Website: http://www.resverlogix.com/


Resverlogix Announces Update Webcast and Conference Call Jan. 18, 2021
Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure Jan. 12, 2021
Resverlogix Announces Voting Results from the 2020 Meeting of Shareholders and Update on $13 Million Investment by Sheikh Abdulgader Aboud Baeshen Dec. 22, 2020
Resverlogix Announces Apabetalone Treatment Prior to SARS-CoV-2 (COVID-19) Exposure Significantly Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial Dec. 22, 2020
What Type Of Shareholders Own The Most Number of Resverlogix Corp. (TSE:RVX) Shares? Dec. 11, 2020